Aimmune Therapeutics soars 172% after Nestle agrees to acquire the peanut allergy treatment company for $.. – Business Insider

0
43
Aimmune Therapeutics soars 172% after Nestle agrees to acquire the peanut allergy treatment company for $.. – Business Insider

Aimmune Therapeutics soars 172% after Nestle agrees to acquire the peanut allergy treatment company for $2.6 billion (AIMT)
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here